BDMD Shariah Compliance
Screening Methodology: AAOIFI
HALAL
Last Updated: December 10, 2025
Report Source: 2025 2nd Quarter Report
Baird Medical Investment Holdings Ltd. Stock Analysis BDMD
Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. The company is headquartered in Guangzhou, Guangdong and currently employs 146 full-time employees. The company went IPO on 2021-12-13. The Company’s MWA medical devices primarily include MWA needles and MWA therapeutic apparatus. The firm is also engaged in the sales of other medical devices, including catheters, ventilators, operation tables, medical gloves, syringes and other large medical machines and systems. The proprietary medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. The firm primarily conducts its businesses in the domestic market.
Read More Baird Medical Investment Holdings Ltd (BDMD) Chart
Key Statistics of Baird Medical Investment Holdings Ltd (BDMD)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$1.68Volume
146.13KP/E Ratio (TTM)
-52 Week Range
Market Cap
74.58MAvg. Volume
213.30KDividend Yield
-Financial Metrics & Statements of Baird Medical Investment Holdings Ltd (BDMD)
FAQ's for Baird Medical Investment Holdings Ltd (BDMD)
- According to Musaffa’s Shariah screening methodology, Baird Medical Investment Holdings Ltd (BDMD) is currently classified as HALAL as of December 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.